These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


244 related items for PubMed ID: 10772636

  • 41. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M, Shindo M, Shimada T.
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [Abstract] [Full Text] [Related]

  • 42. Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formation.
    Miller JL, Trepanier LA.
    Eur J Clin Pharmacol; 2002 Apr; 58(1):69-72. PubMed ID: 11956677
    [Abstract] [Full Text] [Related]

  • 43. Characterization of the selectivity and mechanism of cytochrome P450 inhibition by dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate.
    Kim JY, Baek M, Lee S, Kim SO, Dong MS, Kim BR, Kim DH.
    Drug Metab Dispos; 2001 Dec; 29(12):1555-60. PubMed ID: 11717174
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans.
    Carlile DJ, Hakooz N, Bayliss MK, Houston JB.
    Br J Clin Pharmacol; 1999 Jun; 47(6):625-35. PubMed ID: 10383540
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Cloning of a cDNA encoding a novel marmoset CYP2C enzyme, expression in yeast cells and characterization of its enzymatic functions.
    Narimatsu S, Torigoe F, Tsuneto Y, Saito K, Hanioka N, Masuda K, Katsu T, Yamamoto S, Yamano S, Baba T, Miyata A.
    Biochem Pharmacol; 2006 Dec 15; 72(12):1738-48. PubMed ID: 17010942
    [Abstract] [Full Text] [Related]

  • 53. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.
    Kunze KL, Wienkers LC, Thummel KE, Trager WF.
    Drug Metab Dispos; 1996 Apr 15; 24(4):414-21. PubMed ID: 8801056
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver.
    Leemann T, Transon C, Dayer P.
    Life Sci; 1993 Apr 15; 52(1):29-34. PubMed ID: 8417277
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function.
    Ridderström M, Masimirembwa C, Trump-Kallmeyer S, Ahlefelt M, Otter C, Andersson TB.
    Biochem Biophys Res Commun; 2000 Apr 21; 270(3):983-7. PubMed ID: 10772937
    [Abstract] [Full Text] [Related]

  • 60. Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes.
    Kim KA, Park JY.
    Drug Metab Dispos; 2003 Sep 21; 31(9):1090-2. PubMed ID: 12920163
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.